We are live on
!
Find out more
Parallel Advisors Portfolio holdings
AUM
$6.56B
Turnover
11.49%
1-Year Est. Return
32.24%
This Fund
S&P 500
This Quarter
Est. Return
+8.68%
1 Year Est. Return
+32.24%
3 Year Est. Return
+108.68%
5 Year Est. Return
+114.41%
10 Year Est. Return
–
AUM
$5.46B
AUM Growth
+$457M
(+9.1%)
Cap. Flow
+$77.1M
Cap. Flow
% of AUM
1.41%
Top 10 Holdings %
Top 10 Hldgs %
40.1%
Holding
3,730
New
196
Increased
1,298
Reduced
1,151
Closed
184
Avg Time Held Equity + Options
4.8
years
Top 10 Avg Time Held Equity + Options
3
years
Top 20 Avg Time Held Equity + Options
4
years
Avg Time Held Equity only
4.9
years
Top 10 Avg Time Held Equity only
3
years
Top 20 Avg Time Held Equity only
4
years
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares Core S&P 500 ETF
IVV
|
+$55.8M |
| 2 |
Avantis International Equity ETF
AVDE
|
+$53.6M |
| 3 |
BlackRock US Equity Factor Rotation ETF
DYNF
|
+$22.8M |
| 4 |
PIMCO Ultra Short Government Active ETF
BILZ
|
+$12.1M |
| 5 |
BlackRock Flexible Income ETF
BINC
|
+$9.02M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares S&P 500 Growth ETF
IVW
|
+$43.9M |
| 2 |
iShares Core S&P Total US Stock Market ETF
ITOT
|
+$37.8M |
| 3 |
iShares Core MSCI EAFE ETF
IEFA
|
+$34.6M |
| 4 |
Vanguard Morningstar Large-Cap ETF
VV
|
+$4.55M |
| 5 |
iShares MSCI USA Quality Factor ETF
QUAL
|
+$3.79M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 46.72% |
| 2 | Technology | 17.87% |
| 3 | Healthcare | 9.74% |
| 4 | Financials | 6.73% |
| 5 | Communication Services | 5.56% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
2976
Horizon Kinetics Inflation Beneficiaries ETF
INFL
$1.55B
| $2.23K | ﹤0.01% |
50
| – | – |
2025 Q1
2 quarters
|
|
2977
WisdomTree Floating Rate Treasury Fund
USFR
$20.8B
| $2.21K | ﹤0.01% |
44
| – | – |
2022 Q2
13 quarters
|
|
2978
Phathom Pharmaceuticals
PHAT
$573M
| $2.19K | ﹤0.01% |
186
| – | – |
2025 Q1
2 quarters
|
|
2979
Octave Specialty Group
OSG
$209M
| $2.17K | ﹤0.01% |
260
+245
| +1,633% | +$2.07K |
2025 Q2
1 quarter
|
|
2980
Saul Centers
BFS
$729M
| $2.17K | ﹤0.01% |
68
-33
| -33% | -$1.09K |
2025 Q1
2 quarters
|
|
2981
Sylvamo
SLVM
$1.29B
| $2.17K | ﹤0.01% |
49
| – | – |
2021 Q4
15 quarters
|
|
2982
First Trust Large Cap Value AlphaDEX Fund
FTA
$1.39B
| $2.17K | ﹤0.01% |
26
| – | – |
2023 Q3
8 quarters
|
|
2983
Bristow Group
VTOL
$1.15B
| $2.17K | ﹤0.01% |
60
| – | – |
2021 Q4
15 quarters
|
|
2984
Kura Oncology
KURA
$827M
| $2.15K | ﹤0.01% |
243
-398
| -62% | -$2.84K |
2025 Q2
1 quarter
|
|
2985
Origin Bancorp
OBK
$1.6B
| $2.14K | ﹤0.01% |
62
| – | – |
2021 Q1
18 quarters
|
|
2986
Adtran
ADTN
$516M
| $2.14K | ﹤0.01% |
228
| – | – |
2023 Q1
10 quarters
|
|
2987
Champion Homes
SKY
$4.19B
| $2.14K | ﹤0.01% |
28
| – | – |
2023 Q1
10 quarters
|
|
2988
ProShares UltraPro Russell2000
URTY
$254M
| $2.12K | ﹤0.01% |
40
| – | – |
2024 Q1
6 quarters
|
|
2989
iShares Broad USD High Yield Corporate Bond ETF
USHY
$25.3B
| $2.12K | ﹤0.01% |
56
| – | – |
2020 Q3
20 quarters
|
|
2990
Abeona Therapeutics
ABEO
$253M
| $2.11K | ﹤0.01% |
400
| – | – |
2022 Q1
14 quarters
|
|
2991
Subversive Congressional Democrats Trading ETF
NANC
$288M
| $2.1K | ﹤0.01% |
47
-65
| -58% | -$2.8K |
2024 Q3
4 quarters
|
|
2992
Amplify Junior Silver Miners ETF
SILJ
$3.3B
| $2.1K | ﹤0.01% |
91
| – | – |
2024 Q4
3 quarters
|
|
2993
Ceco Environmental
CECO
$3.37B
| $2.1K | ﹤0.01% |
41
| – | – |
2022 Q3
12 quarters
|
|
2994
Victoria's Secret
VSXY
$7.04B
| $2.09K | ﹤0.01% |
77
| – | – |
2021 Q3
16 quarters
|
|
2995
Baldwin Insurance Group
BWIN
$4.49B
| $2.09K | ﹤0.01% |
74
| – | – |
2023 Q3
8 quarters
|
|
2996
Ryanair
RYAAY
$27.1B
| $2.08K | ﹤0.01% |
34
+7
| +26% | +$427 |
2022 Q2
13 quarters
|
|
2997
YieldMax COIN Option Income Strategy ETF
CONY
$363M
| $2.06K | ﹤0.01% |
30
+10
| +50% | +$787 |
2024 Q4
3 quarters
|
|
2998
HNI Corp
HNI
$3.38B
| $2.06K | ﹤0.01% |
44
| – | – |
2020 Q1
22 quarters
|
|
2999
Cardiff Oncology
CRDF
$72.7M
| $2.06K | ﹤0.01% |
1,000
| – | – |
2025 Q1
2 quarters
|
|
3000
Allot
ALLT
$442M
| $2.05K | ﹤0.01% |
194
-109
| -36% | -$925 |
2025 Q1
2 quarters
|
|
Similar funds
Parallel Advisors's Q3 2025 Portfolio in Review
As of Q3 2025, Parallel Advisors held 3,730 positions worth $5.46B, up 9.1% from $5B the previous quarter. Its ten largest holdings account for 40% of the portfolio.
Parallel Advisors's Q3 2025 filing shows 196 new, 1,298 increased, 1,151 reduced and 184 closed positions. Its largest new stake was Avantis Emerging Markets Equity ETF: 36,371 shares worth $2.73M. The largest sale was iShares S&P 500 Growth ETF, an estimated $43.9M.
By sector, the portfolio is most concentrated in Miscellaneous at 47% of assets, up from 47% a quarter earlier, followed by Technology and Healthcare.
- Parallel Advisors's largest Q3 2025 buy was Avantis Emerging Markets Equity ETF: 36,371 shares worth $2.73M.
- Parallel Advisors added most to iShares Core S&P 500 ETF in Q3 2025, an estimated $55.8M increase.
- Parallel Advisors's biggest Q3 2025 reduction was iShares S&P 500 Growth ETF, cutting an estimated $43.9M.
- Parallel Advisors fully exited PIMCO Municipal Income Fund II in Q3 2025, selling an estimated $1.46M.
- Parallel Advisors's ten largest holdings make up 40% of its $5.46B portfolio in Q3 2025.
- Parallel Advisors opened 196 new positions and closed 184 in Q3 2025.
- Parallel Advisors's portfolio value rose 9.1% quarter-over-quarter to $5.46B.
Based on Parallel Advisors's 13F filing for Q3 2025, filed 13 Nov 2025.